Contrary to the decade-long trend of outsourcing to CDMOs, major pharmaceutical companies are now vertically re-integrating their supply chains. Driven by supply chain vulnerabilities, they now view manufacturing not as a cost center but as a strategic advantage, creating opportunities for technology enablers rather than just capacity providers.

Excel Data exemplifies a modern global startup structure. With three of four co-founders based in India, they built their core tech team there to leverage the big data talent pool. Meanwhile, the CEO relocated to the Bay Area to establish the go-to-market and sales functions, capitalizing on both regions' strengths.

When deciding to build or buy, the key factor is strategic importance. Never cede control of technology that is core to your unique value proposition to a vendor. Reserve outsourcing for necessary but commoditized functions that don't differentiate you in the market.

Companies like AstraZeneca and Volkswagen are no longer just selling to China; they are moving their core research and development there. They recognize that to remain globally competitive, they must tap into China's advanced R&D ecosystem and burgeoning pool of highly educated talent, marking a fundamental shift in China's role in the global economy.

While massive data consumption is a key driver, India's data center growth is significantly accelerated by government regulations. Mandates requiring financial institutions and other entities to house client data within the country create a guaranteed, protected demand for local infrastructure.

The fear was that AI would eliminate outsourced coding jobs. Instead, the complexity of integrating AI with legacy business systems has created a new opportunity. Indian IT firms are now being hired as consultants to reconfigure clients' operations for AI, turning a potential job-killer into a significant source of revenue.

Vinod Khosla warns that AI will decimate the traditional business process outsourcing and IT services sectors, which are foundational to India's economy. Incumbent firms face extinction unless they radically reinvent their business models.

Vivtex avoids outsourcing critical R&D because external partners and CROs cannot match the speed of a startup team whose very existence depends on solving problems quickly. This internal urgency is a core competitive advantage that is lost when relying on third parties with different priorities.

Companies, especially in early stages, should resist outsourcing production too quickly. Keeping a new process in-house is essential for understanding its pain points, which is a prerequisite for being able to specify clear, effective requirements to an external vendor later on.